Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects

Sohee Son, Sung Mook Lim, Su Young Chae, Kwang Meyung Kim, Eun Ji Park, Kang Choon Lee, Dong Hee Na

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Hydrophobically modified glycol chitosan (HGC) nanoparticles loaded with mono-lithocholic acid-conjugated exendin-4 at the Lys27 residue (LAM1-Ex4) were prepared and characterized by particle size measurement, proteolytic stability, in vitro drug-release profile, and in vivo antidiabetic effects in a db/db diabetic mouse model. Compared with Ex-4-loaded HGC nanoparticles (Ex4/HGC NPs) prepared as a control, LAM1-Ex4-loaded HGC nanoparticles (LAM1-Ex4/HGC NPs) showed improved drug-loading efficiency, small particle size, enhanced resistance against proteolytic digestion, and an extended in vitro drug release profile. These findings may be attributable to the strong hydrophobic interaction between LAM1-Ex4 and the inner core of HGC. Furthermore, LAM1-Ex4/HGC NPs showed prolonged hypoglycemic efficacy in db/db mice, lasting 1 week after a single subcutaneous administration. The present study demonstrated that LAM1-Ex4/HGC NPs have considerable potential as a long-acting sustained-release antidiabetic system for type 2 diabetes.

Original languageEnglish
Pages (from-to)81-86
Number of pages6
JournalInternational Journal of Pharmaceutics
Volume495
Issue number1
DOIs
Publication statusPublished - 2015 Nov 10
Externally publishedYes

Fingerprint

Hypoglycemic Agents
Nanoparticles
Particle Size
Lithocholic Acid
Hydrophobic and Hydrophilic Interactions
Type 2 Diabetes Mellitus
exenatide
glycol-chitosan
Digestion
Pharmaceutical Preparations

Keywords

  • Antidiabetic effects
  • Exendin-4
  • Glycol chitosan
  • Lithocholic acid
  • Nanoparticles

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects. / Son, Sohee; Lim, Sung Mook; Chae, Su Young; Kim, Kwang Meyung; Park, Eun Ji; Lee, Kang Choon; Na, Dong Hee.

In: International Journal of Pharmaceutics, Vol. 495, No. 1, 10.11.2015, p. 81-86.

Research output: Contribution to journalArticle

Son, Sohee ; Lim, Sung Mook ; Chae, Su Young ; Kim, Kwang Meyung ; Park, Eun Ji ; Lee, Kang Choon ; Na, Dong Hee. / Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects. In: International Journal of Pharmaceutics. 2015 ; Vol. 495, No. 1. pp. 81-86.
@article{1da32e5e4d4f4f71a566e3f790c76ace,
title = "Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects",
abstract = "Hydrophobically modified glycol chitosan (HGC) nanoparticles loaded with mono-lithocholic acid-conjugated exendin-4 at the Lys27 residue (LAM1-Ex4) were prepared and characterized by particle size measurement, proteolytic stability, in vitro drug-release profile, and in vivo antidiabetic effects in a db/db diabetic mouse model. Compared with Ex-4-loaded HGC nanoparticles (Ex4/HGC NPs) prepared as a control, LAM1-Ex4-loaded HGC nanoparticles (LAM1-Ex4/HGC NPs) showed improved drug-loading efficiency, small particle size, enhanced resistance against proteolytic digestion, and an extended in vitro drug release profile. These findings may be attributable to the strong hydrophobic interaction between LAM1-Ex4 and the inner core of HGC. Furthermore, LAM1-Ex4/HGC NPs showed prolonged hypoglycemic efficacy in db/db mice, lasting 1 week after a single subcutaneous administration. The present study demonstrated that LAM1-Ex4/HGC NPs have considerable potential as a long-acting sustained-release antidiabetic system for type 2 diabetes.",
keywords = "Antidiabetic effects, Exendin-4, Glycol chitosan, Lithocholic acid, Nanoparticles",
author = "Sohee Son and Lim, {Sung Mook} and Chae, {Su Young} and Kim, {Kwang Meyung} and Park, {Eun Ji} and Lee, {Kang Choon} and Na, {Dong Hee}",
year = "2015",
month = "11",
day = "10",
doi = "10.1016/j.ijpharm.2015.08.084",
language = "English",
volume = "495",
pages = "81--86",
journal = "International Journal of Pharmaceutics",
issn = "0378-5173",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Mono-lithocholated exendin-4-loaded glycol chitosan nanoparticles with prolonged antidiabetic effects

AU - Son, Sohee

AU - Lim, Sung Mook

AU - Chae, Su Young

AU - Kim, Kwang Meyung

AU - Park, Eun Ji

AU - Lee, Kang Choon

AU - Na, Dong Hee

PY - 2015/11/10

Y1 - 2015/11/10

N2 - Hydrophobically modified glycol chitosan (HGC) nanoparticles loaded with mono-lithocholic acid-conjugated exendin-4 at the Lys27 residue (LAM1-Ex4) were prepared and characterized by particle size measurement, proteolytic stability, in vitro drug-release profile, and in vivo antidiabetic effects in a db/db diabetic mouse model. Compared with Ex-4-loaded HGC nanoparticles (Ex4/HGC NPs) prepared as a control, LAM1-Ex4-loaded HGC nanoparticles (LAM1-Ex4/HGC NPs) showed improved drug-loading efficiency, small particle size, enhanced resistance against proteolytic digestion, and an extended in vitro drug release profile. These findings may be attributable to the strong hydrophobic interaction between LAM1-Ex4 and the inner core of HGC. Furthermore, LAM1-Ex4/HGC NPs showed prolonged hypoglycemic efficacy in db/db mice, lasting 1 week after a single subcutaneous administration. The present study demonstrated that LAM1-Ex4/HGC NPs have considerable potential as a long-acting sustained-release antidiabetic system for type 2 diabetes.

AB - Hydrophobically modified glycol chitosan (HGC) nanoparticles loaded with mono-lithocholic acid-conjugated exendin-4 at the Lys27 residue (LAM1-Ex4) were prepared and characterized by particle size measurement, proteolytic stability, in vitro drug-release profile, and in vivo antidiabetic effects in a db/db diabetic mouse model. Compared with Ex-4-loaded HGC nanoparticles (Ex4/HGC NPs) prepared as a control, LAM1-Ex4-loaded HGC nanoparticles (LAM1-Ex4/HGC NPs) showed improved drug-loading efficiency, small particle size, enhanced resistance against proteolytic digestion, and an extended in vitro drug release profile. These findings may be attributable to the strong hydrophobic interaction between LAM1-Ex4 and the inner core of HGC. Furthermore, LAM1-Ex4/HGC NPs showed prolonged hypoglycemic efficacy in db/db mice, lasting 1 week after a single subcutaneous administration. The present study demonstrated that LAM1-Ex4/HGC NPs have considerable potential as a long-acting sustained-release antidiabetic system for type 2 diabetes.

KW - Antidiabetic effects

KW - Exendin-4

KW - Glycol chitosan

KW - Lithocholic acid

KW - Nanoparticles

UR - http://www.scopus.com/inward/record.url?scp=84940727466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940727466&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2015.08.084

DO - 10.1016/j.ijpharm.2015.08.084

M3 - Article

C2 - 26325318

AN - SCOPUS:84940727466

VL - 495

SP - 81

EP - 86

JO - International Journal of Pharmaceutics

JF - International Journal of Pharmaceutics

SN - 0378-5173

IS - 1

ER -